HOME >> BIOLOGY >> NEWS
First clinical study of new pediatric croup vaccine shows safety, tolerability in adults

d Allen Portner, Ph.D., member of the department of Infectious Diseases and a co-author of the paper. "First, it appears likely that this virus will provide immunity against hPIV-1 in infants. Second, despite the fact that children frequently have close contact with mice carrying SeV, there has never been a confirmed case of SeV infection in humans." Using a natural mimic of a human virus follows in the tradition of the world's most successful vaccine, the smallpox vaccine, said Julia Hurwitz, Ph.D. member of the department of Immunology.

"The smallpox vaccine was based on the cowpox virus, which caused only limited skin infection in healthy humans," Hurwitz said. "Yet it provided lifelong protection against smallpox and eradicated this disease from the human population in the 1970s. We hope that SeV will similarly help eradicate hPIV-1 as a cause of childhood croup."


'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
23-Aug-2004


Page: 1 2

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. 2nd media alert First Scientific Conference on Childhood Leukaemia
3. First International Scientific Conference on Childhood Leukaemia
4. First ever standards linking climate change, biodiversity and poverty seek global peer review
5. First genetic comparison of purebred domestic dogs produces surprises
6. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
7. First target for childhood malaria vaccine
8. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
9. First flavors form a lasting impression
10. STN International launches Derwent World Patents Index First View
11. First DFG research conference in the USA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2019)... ... 2019 , ... According to the World Health Organization , over a ... chlamydia, gonorrhea, trichomoniasis (or "trich") and syphilis. And that’s not counting HIV. , ... accounted for the largest number of HIV diagnoses (9,807), followed by Hispanic/Latino men (7,436) ...
(Date:6/18/2019)... , ... June 18, 2019 , ... ... learning cloud solutions, today introduced Data Science Workstations-as-a-Service as part of its dedicated, ... from BOXX Technologies, Cirrascale Data Science Workstations feature NVIDIA® Quadro RTX™ GPUs for ...
(Date:6/14/2019)... , ... June 14, 2019 , ... Molecular diagnostics segment ... to be $8,760 million in 2019. Major segments that are expected to drive ... all broken out and forecasted as segments in Kalorama’s The World Molecular Diagnostics ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... ... ... For many years, the primary forms of cancer treatment have been chemotherapy, radiation and ... led to the advent of Chimeric Antigen Receptor T (CAR T) cell therapy, which ... The CAR enables the final product to produce chemicals in the hopes that the ...
(Date:5/31/2019)... ... May 30, 2019 , ... ... demonstrate an efficient delivery system for the sustained release of human placental stem ... gel system was able to deliver CM into the injured kidney, where it ...
(Date:5/15/2019)... RIVER FALLS, Wis. (PRWEB) , ... May 16, ... ... uniform oil and water mixtures. As a result, food and beverage products rely ... However, today, consumers demand more natural sounding label declarations. This paradigm shift triggers ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The new Liquid Nitrogen Best ... being asked to store cellular products being used in adoptive therapy research ... world leaders, who have shared their expertise in building and managing facilities to ...
Breaking Biology Technology:
Cached News: